AN2 Therapeutics, Inc. reports

Location
1800 El Camino Real, Suite D, Menlo Park, CA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
11/13/2024, 04:06 PM
Form type Sec Links Description Filing date Reporting date
10-Q Report | Data 10-Q Nov 13, 2024 Sep 30, 2024
8-K Report | Data 8-K Nov 13, 2024 Nov 13, 2024
8-K Report | Data 8-K Nov 5, 2024 Nov 4, 2024
SC 13G/A Report AMENDMENT NO. 1 Aug 28, 2024
8-K Report | Data 8-K Aug 19, 2024 Aug 15, 2024
SC 13G/A Report Aug 14, 2024
SC 13G/A Report SC 13G/A Aug 13, 2024
10-Q Report | Data 10-Q Aug 13, 2024 Jun 30, 2024
8-K Report | Data 8-K Aug 13, 2024 Aug 13, 2024
SC 13G Report Aug 12, 2024
8-K Report | Data 8-K Aug 8, 2024 Aug 7, 2024
SC 13G Report Jul 3, 2024
8-K Report | Data 8-K Jun 24, 2024 Jun 19, 2024
10-Q Report | Data 10-Q May 14, 2024 Mar 31, 2024
8-K Report | Data 8-K May 14, 2024 May 14, 2024
10-K/A Report | Data 10-K/A May 14, 2024 Dec 31, 2023
SC 13G Report SC 13G Apr 10, 2024
10-K Report | Data 10-K Mar 29, 2024 Dec 31, 2023
8-K Report | Data 8-K Mar 28, 2024 Mar 28, 2024
SC 13G/A Report SC 13G/A Feb 14, 2024
SC 13G/A Report SC 13G/A Feb 14, 2024
SC 13G/A Report SC 13G A AN2 Feb 14, 2024
SC 13G Report SC 13G Feb 13, 2024
SC 13G/A Report JHG PLC AND JHBIF OWN <5% Feb 12, 2024
8-K Report | Data 8-K Feb 12, 2024 Feb 12, 2024
SC 13G/A Report SC 13G/A Feb 9, 2024
SC 13G/A Report SC 13G/A Feb 9, 2024
10-Q Report | Data 10-Q Nov 9, 2023 Sep 30, 2023
8-K Report | Data 8-K Nov 9, 2023 Nov 9, 2023
8-K Report | Data 8-K Sep 13, 2023 Sep 13, 2023
8-K Report | Data 8-K Sep 8, 2023 Sep 1, 2023
8-K Report | Data 8-K Aug 16, 2023 Aug 15, 2023
10-Q Report | Data 10-Q Aug 10, 2023 Jun 30, 2023
8-K Report | Data 8-K Aug 10, 2023 Aug 10, 2023
SC 13G Report SC 13G Jul 25, 2023
SC 13G Report BIOTECH (NON-RIC) OWNS 5% Jul 5, 2023
8-K Report | Data 8-K Jun 9, 2023 Jun 7, 2023
10-Q Report | Data 10-Q May 11, 2023 Mar 31, 2023
8-K Report | Data 8-K May 11, 2023 May 11, 2023
10-K Report | Data 10-K Mar 29, 2023 Dec 31, 2022
8-K Report | Data 8-K Mar 29, 2023 Mar 29, 2023
SC 13G/A Report SC 13G/A Feb 14, 2023
SC 13G/A Report AMENDMENT NO. 1 TO THE SCHEDULE 13G Feb 14, 2023
SC 13G/A Report SC 13G/A Feb 14, 2023
SC 13G Report SC 13G Feb 13, 2023
SC 13G Report SC 13G AN2 THERAPEUTICS Feb 13, 2023
SC 13G Report SC 13G Feb 10, 2023
10-Q Report | Data 10-Q Nov 9, 2022 Sep 30, 2022
8-K Report | Data 8-K Nov 9, 2022 Nov 9, 2022
8-K Report | Data 8-K Oct 6, 2022 Oct 6, 2022
10-Q Report | Data 10-Q Aug 11, 2022 Jun 30, 2022
8-K Report | Data 8-K Aug 11, 2022 Aug 11, 2022
8-K Report | Data 8-K Jun 29, 2022 Jun 29, 2022
10-Q Report | Data 10-Q May 10, 2022 Mar 31, 2022
8-K Report | Data 8-K May 10, 2022 May 10, 2022
8-K Report 8-K May 9, 2022 May 5, 2022
SC 13G Report AN2 THERAPEUTICS, INC. Apr 8, 2022
SC 13G Report AN2 THERAPEUTICS, INC. Apr 8, 2022
SC 13G Report THE SCHEDULE 13G Apr 4, 2022